This investment represents the most recent installment of UPS’s ongoing commitment to serve the distinctive needs of healthcare clients around the world. UPS announced the expansion of its healthcare distribution network in the Asia-Pacific region in October 2012, with the opening of three new facilities in Hangzhou, China, Shanghai, China and Sydney, Australia.
Several industry trends are driving the expansion of UPS’s global healthcare network, including increasing globalization complex regulatory oversight, heightened focus on outcomes and a growing need for specialized healthcare services, such as temperature-sensitive solutions. The latest expansions were driven by the growth of UPS’s healthcare customers and the UPS global healthcare strategy that supports customers as they grow and adapt to these trends.
“UPS is committed to investing in our global network and supporting industry demand to meet customer needs for increased speed, flexibility and efficiency,” said Bill Hook, vice president, global strategy, UPS Healthcare Logistics. “Our healthcare customers are creating value through our broad network and single global technology platform.”
UPS facilities meet all applicable government accreditations, licenses and maintain geographic-specific regulatory requirements, such as those of the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA) and Health Canada, among hundreds of others.
UPS healthcare facilities offer distribution space with temperature and humidity-controlled environments which help keep products in optimal conditions during storage. Each of the expanded facilities is designed to serve the warehousing and distribution needs of pharmaceutical and medical device manufacturers.
This investment represents the most recent installment of UPS’s ongoing commitment to serve the distinctive needs of healthcare clients around the world. UPS announced the expansion of its healthcare distribution network in the Asia-Pacific region in October 2012, with the opening of three new facilities in Hangzhou, China, Shanghai, China and Sydney, Australia.
Several industry trends are driving the expansion of UPS’s global healthcare network, including increasing globalization complex regulatory oversight, heightened focus on outcomes and a growing need for specialized healthcare services, such as temperature-sensitive solutions. The latest expansions were driven by the growth of UPS’s healthcare customers and the UPS global healthcare strategy that supports customers as they grow and adapt to these trends.
“UPS is committed to investing in our global network and supporting industry demand to meet customer needs for increased speed, flexibility and efficiency,” said Bill Hook, vice president, global strategy, UPS Healthcare Logistics. “Our healthcare customers are creating value through our broad network and single global technology platform.”
UPS facilities meet all applicable government accreditations, licenses and maintain geographic-specific regulatory requirements, such as those of the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA) and Health Canada, among hundreds of others.
UPS healthcare facilities offer distribution space with temperature and humidity-controlled environments which help keep products in optimal conditions during storage. Each of the expanded facilities is designed to serve the warehousing and distribution needs of pharmaceutical and medical device manufacturers.